Literature DB >> 22876038

Moro orange juice prevents fatty liver in mice.

Federico Salamone1, Giovanni Li Volti, Lucilla Titta, Lidia Puzzo, Ignazio Barbagallo, Francesco La Delia, Shira Zelber-Sagi, Michele Malaguarnera, Pier Giuseppe Pelicci, Marco Giorgio, Fabio Galvano.   

Abstract

AIM: To establish if the juice of Moro, an anthocyanin-rich orange, may improve liver damage in mice with diet-induced obesity.
METHODS: Eight-week-old mice were fed a high-fat diet (HFD) and were administrated water or Moro juice for 12 wk. Liver morphology, gene expression of lipid transcription factors, and metabolic enzymes were assessed.
RESULTS: Mice fed HFD displayed increased body weight, insulin resistance and dyslipidemia. Moro juice administration limited body weight gain, enhanced insulin sensitivity, and decreased serum triglycerides and total cholesterol. Mice fed HFD showed liver steatosis associated with ballooning. Dietary Moro juice markedly improved liver steatosis by inducing the expression of peroxisome proliferator-activated receptor-α and its target gene acylCoA-oxidase, a key enzyme of lipid oxidation. Consistently, Moro juice consumption suppressed the expression of liver X receptor-α and its target gene fatty acid synthase, and restored liver glycerol-3-phosphate acyltransferase 1 activity.
CONCLUSION: Moro juice counteracts liver steatogenesis in mice with diet-induced obesity and thus may represent a promising dietary option for the prevention of fatty liver.

Entities:  

Keywords:  Anthocyanins; Lipid oxidation; Lipogenesis; Liver steatosis

Mesh:

Substances:

Year:  2012        PMID: 22876038      PMCID: PMC3413058          DOI: 10.3748/wjg.v18.i29.3862

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C.

Authors:  Elena Lima-Cabello; María Victoria García-Mediavilla; María E Miquilena-Colina; Javier Vargas-Castrillón; Tamara Lozano-Rodríguez; Miguel Fernández-Bermejo; José Luis Olcoz; Javier González-Gallego; Carmelo García-Monzón; Sonia Sánchez-Campos
Journal:  Clin Sci (Lond)       Date:  2011-03       Impact factor: 6.124

Review 2.  Systematic review of long-term lifestyle interventions to prevent weight gain and morbidity in adults.

Authors:  T Brown; A Avenell; L D Edmunds; H Moore; V Whittaker; L Avery; C Summerbell
Journal:  Obes Rev       Date:  2009-09-14       Impact factor: 9.213

Review 3.  Molecular biology and functional genomics of liver X receptors (LXR) in relationship to metabolic diseases.

Authors:  Malin Hedengran Faulds; Chunyan Zhao; Karin Dahlman-Wright
Journal:  Curr Opin Pharmacol       Date:  2010-09-09       Impact factor: 5.547

4.  Effects of protocatechuic acid on trans fat induced hepatic steatosis in mice.

Authors:  Wen-Hu Liu; Chun-Che Lin; Zhi-Hong Wang; Mei-Chin Mong; Mei-Chin Yin
Journal:  J Agric Food Chem       Date:  2010-09-22       Impact factor: 5.279

Review 5.  Bioavailability, antioxidant and biological properties of the natural free-radical scavengers cyanidin and related glycosides.

Authors:  Fabio Galvano; Luca La Fauci; Paola Vitaglione; Vincenzo Fogliano; Luca Vanella; Catherine Felgines
Journal:  Ann Ist Super Sanita       Date:  2007       Impact factor: 1.663

6.  Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.

Authors:  Kevin M Korenblat; Elisa Fabbrini; B Selma Mohammed; Samuel Klein
Journal:  Gastroenterology       Date:  2008-01-30       Impact factor: 22.682

7.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.

Authors:  Elisa Fabbrini; Faidon Magkos; B Selma Mohammed; Terri Pietka; Nada A Abumrad; Bruce W Patterson; Adewole Okunade; Samuel Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

8.  Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study.

Authors:  Shira Zelber-Sagi; Dorit Nitzan-Kaluski; Rebecca Goldsmith; Muriel Webb; Laurie Blendis; Zamir Halpern; Ran Oren
Journal:  J Hepatol       Date:  2007-08-14       Impact factor: 25.083

Review 9.  Cyanidins: metabolism and biological properties.

Authors:  Fabio Galvano; Luca La Fauci; Giuseppe Lazzarino; Vincenzo Fogliano; Alberto Ritieni; Salvatore Ciappellano; Nino C Battistini; Barbara Tavazzi; Giacomo Galvano
Journal:  J Nutr Biochem       Date:  2004-01       Impact factor: 6.048

10.  Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.

Authors:  Hee Yeon Kay; Won Dong Kim; Se Jin Hwang; Hueng-Sik Choi; Richard K Gilroy; Yu-Jui Yvonne Wan; Sang Geon Kim
Journal:  Antioxid Redox Signal       Date:  2011-06-13       Impact factor: 8.401

View more
  20 in total

Review 1.  Dietary anthocyanins and health: data from FLORA and ATHENA EU projects.

Authors:  Chiara Cerletti; Amalia De Curtis; Francesca Bracone; Cinzia Digesù; Alessio G Morganti; Licia Iacoviello; Giovanni de Gaetano; Maria Benedetta Donati
Journal:  Br J Clin Pharmacol       Date:  2016-05-29       Impact factor: 4.335

Review 2.  Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials.

Authors:  Shira Zelber-Sagi; Justyna Godos; Federico Salomone
Journal:  Therap Adv Gastroenterol       Date:  2016-03-17       Impact factor: 4.409

3.  Pathophysiology of NASH: perspectives for a targeted treatment.

Authors:  Fabio Marra; Sophie Lotersztajn
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

4.  Blond and blood juice supplementation in high fat diet fed mice: effect on antioxidant status and DDAH/ADMA pathway.

Authors:  V Sorrenti; C Di Giacomo; R Acquaviva; J Cosenza; G Carota; F Galvano
Journal:  RSC Adv       Date:  2019-04-11       Impact factor: 4.036

Review 5.  Mediterranean diet and health: food effects on gut microbiota and disease control.

Authors:  Federica Del Chierico; Pamela Vernocchi; Bruno Dallapiccola; Lorenza Putignani
Journal:  Int J Mol Sci       Date:  2014-07-01       Impact factor: 5.923

Review 6.  Red orange: experimental models and epidemiological evidence of its benefits on human health.

Authors:  Giuseppe Grosso; Fabio Galvano; Antonio Mistretta; Stefano Marventano; Francesca Nolfo; Giorgio Calabrese; Silvio Buscemi; Filippo Drago; Umberto Veronesi; Alessandro Scuderi
Journal:  Oxid Med Cell Longev       Date:  2013-05-02       Impact factor: 6.543

7.  Blueberry and mulberry juice prevent obesity development in C57BL/6 mice.

Authors:  Tao Wu; Qiong Tang; Zichun Gao; Zhuoping Yu; Haizhao Song; Xiaodong Zheng; Wei Chen
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

Review 8.  Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease.

Authors:  Luca Valenti; Patrizia Riso; Alessandra Mazzocchi; Marisa Porrini; Silvia Fargion; Carlo Agostoni
Journal:  Oxid Med Cell Longev       Date:  2013-10-24       Impact factor: 6.543

Review 9.  Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.

Authors:  William Peverill; Lawrie W Powell; Richard Skoien
Journal:  Int J Mol Sci       Date:  2014-05-14       Impact factor: 5.923

Review 10.  Modulation of PPAR Expression and Activity in Response to Polyphenolic Compounds in High Fat Diets.

Authors:  J Abraham Domínguez-Avila; Gustavo A González-Aguilar; Emilio Alvarez-Parrilla; Laura A de la Rosa
Journal:  Int J Mol Sci       Date:  2016-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.